UroGen Pharma Ltd.
DE ˙ DB ˙ IL0011407140
€ 23,18 ↑0.82 (3.67%)
2026-06-05
PREÇO DA AÇÃO
SecurityDE:UR8 / UroGen Pharma Ltd.
InstitutionVanguard Group Inc
Latest Disclosed Ownership439,751 shares
Latest Disclosed Value $ 10,298,969
Vanguard Group Inc reports 44.76% increase in ownership of UR8 / UroGen Pharma Ltd.

On January 29, 2026 - Vanguard Group Inc filed a 13F-HR form disclosing ownership of 439,751 shares of UroGen Pharma Ltd. (DE:UR8) valued at $8,487,194 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 7, 2025 disclosing 303,785 shares of UroGen Pharma Ltd.. This represents a change in shares of 44.76% during the quarter. The current value of the position is $10,193,428 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F UROGEN PHARMA COM M96088105 439,751 135,966 44.76 10,299 69.93 0.0001
2025-11-07 2025-09-30 13F UROGEN PHARMA COM M96088105 303,785 48,814 19.14 6,061 73.49 0.0001
2025-08-11 2025-06-30 13F UROGEN PHARMA COM M96088105 254,971 4,542 1.81 3,493 26.15 0.0001
2025-05-09 2025-03-31 13F UROGEN PHARMA COM M96088105 250,429 -46,925 -15.78 2,770 -12.54 0.0001
2025-02-11 2024-12-31 13F UROGEN PHARMA COM M96088105 297,354 12,917 4.54 3,167 -12.35 0.0001
2024-11-13 2024-09-30 13F UROGEN PHARMA COM M96088105 284,437 60,455 26.99 3,612 -3.89 0.0001
2024-08-13 2024-06-30 13F UROGEN PHARMA COM M96088105 223,982 29,016 14.88 3,758 28.52 0.0001
2024-05-10 2024-03-31 13F UROGEN PHARMA COM M96088105 194,966 24,367 14.28 2,924 14.31 0.0001
2024-03-11 2023-12-31 13F/A-1 UROGEN PHARMA COM M96088105 170,599 58,765 52.55 2,559 63.35 0.0001
2024-02-14 2023-12-31 13F UROGEN PHARMA COM M96088105 170,599 58,765 2,559 0.0000
2023-12-18 2023-09-30 13F/A-1 UROGEN PHARMA COM M96088105 111,834 12,019 12.04 1,567 51.60 0.0000
2023-11-14 2023-09-30 13F UROGEN PHARMA COM M96088105 111,834 12,019 1,567 0.0000
2023-08-14 2023-06-30 13F UROGEN PHARMA COM M96088105 99,815 99,815 1,033 0.0000
2022-08-12 2022-06-30 13F UROGEN PHARMA COM M96088105 0 -106,468 -100.00 0 -100.00
2022-05-13 2022-03-31 13F UROGEN PHARMA COM M96088105 106,468 -248 -0.23 927 -8.67 0.0000
2022-02-14 2021-12-31 13F UROGEN PHARMA COM M96088105 106,716 3,518 3.41 1,015 -41.50 0.0000
2021-11-12 2021-09-30 13F UROGEN PHARMA COM M96088105 103,198 6,828 7.09 1,735 17.95 0.0000
2021-08-13 2021-06-30 13F UROGEN PHARMA COM M96088105 96,370 3,647 3.93 1,471 -18.59 0.0000
2021-05-14 2021-03-31 13F UROGEN PHARMA COM M96088105 92,723 9,494 11.41 1,807 20.47 0.0000
2021-02-12 2020-12-31 13F UROGEN PHARMA COM M96088105 83,229 8,304 11.08 1,500 3.81 0.0000
2020-11-16 2020-09-30 13F UROGEN PHARMA COM M96088105 74,925 -3,080 -3.95 1,445 -29.06 0.0000
2020-08-14 2020-06-30 13F UROGEN PHARMA COM M96088105 78,005 -3,220 -3.96 2,037 40.48 0.0001
2020-05-15 2020-03-31 13F UROGEN PHARMA COM M96088105 81,225 636 0.79 1,450 -46.10 0.0001
2020-02-14 2019-12-31 13F UROGEN PHARMA COM M96088105 80,589 -1,419 -1.73 2,690 37.67 0.0001
2019-11-14 2019-09-30 13F UROGEN PHARMA COM M96088105 82,008 11,709 16.66 1,954 -22.64 0.0001
2019-08-14 2019-06-30 13F UROGEN PHARMA COM M96088105 70,299 62,778 834.70 2,526 808.63 0.0001
2019-05-15 2019-03-31 13F UROGEN PHARMA COM M96088105 7,521 7,521 278 0.0000
2018-11-23 2018-09-30 13F/A-1 UROGEN PHARMA COM M96088105 0 -4,163 -100.00 0 -100.00
2018-08-14 2018-06-30 13F UROGEN PHARMA COM M96088105 4,163 4,163 208 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.